» Articles » PMID: 17182440

Plasticity of Mesangial Cells: a Basis for Understanding Pathological Alterations

Overview
Publisher Informa Healthcare
Date 2006 Dec 22
PMID 17182440
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In the last two decades, the ability of mesangial cells to respond to various stimuli or injurious agents by altering their phenotype and function has become recognized. The plasticity of these mesangial cells has been linked to the morphological and functional alterations responsible for the pathologic findings. Many of the glomerular disorders target the mesangium as the primary and/or initial site of injury. Understanding how mesangial cells are altered in the various conditions provides a platform for conceptualizing pathologic mechanisms and defining key steps amenable to therapeutic intervention. The present paper reviews the normal and altered mesangium with an emphasis on mechanisms involved in alterations of mesangial homeostasis. Mesangial cells and matrix are very important in maintaining normal glomerular structure, and function and the plasticity of these cells is responsible for pathological manifestations, repair, and scarring. Our more sophisticated understanding of mesangial cell behavior and matrix biology provides very useful information to help design new therapeutic approaches to the treatment of renal diseases. The potential for bone marrow-derived cells to differentiate into mesangial cells and repopulate damaged mesangium, thus "healing" what is today considered to be irreversible damage represents an exciting new area of research.

Citing Articles

Macrophages communicate with mesangial cells through the CXCL12/DPP4 axis in lupus nephritis pathogenesis.

Li W, Yao C, Guo H, Ni X, Zhu R, Wang Y Cell Death Dis. 2024; 15(5):344.

PMID: 38762508 PMC: 11102518. DOI: 10.1038/s41419-024-06708-4.


AL(light chain)-amyloidogenesis by mesangial cells involves active participation of lysosomes: An ultrastructural study.

Herrera G, Teng J, Zeng C, Del Pozo-Yauner L, Liu B, Turbat-Herrera E Heliyon. 2023; 9(4):e15190.

PMID: 37095940 PMC: 10122028. DOI: 10.1016/j.heliyon.2023.e15190.


Mesangial cell: A hub in lupus nephritis.

Liu M, Zhang L, Wang Y, Hu W, Wang C, Wen Z Front Immunol. 2023; 13:1063497.

PMID: 36591251 PMC: 9795068. DOI: 10.3389/fimmu.2022.1063497.


Hypertensive Nephropathy: Unveiling the Possible Involvement of Hemichannels and Pannexons.

Lucero C, Prieto-Villalobos J, Marambio-Ruiz L, Balmazabal J, Alvear T, Vega M Int J Mol Sci. 2022; 23(24).

PMID: 36555574 PMC: 9785367. DOI: 10.3390/ijms232415936.


Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease.

Herrera G, Teng J, Turbat-Herrera E, Zeng C, Del Pozo-Yauner L Kidney Int Rep. 2020; 5(11):1870-1893.

PMID: 33163710 PMC: 7609979. DOI: 10.1016/j.ekir.2020.07.013.